Carmen Diana H.
- Country
- Germany
- Department
- Klinik und Poliklinik für Hämatologie,Zelltherapie,Hämostaseologie,Infek
Research Overview
- Evaluation of the Safety and Preliminary Efficacy of VAY736 Monotherapy and in Combination with Antineoplastic Agents in Relapsed/Refractory Non-Hodgkin Lymphoma Patients
- A phase 3 multicentre, randomized, prospective, open-label trial of Ibrutinib monotherapy versus fixed-duration Venetoclax plus Obinutuzumab versus fixed-duration Venetoclax plus Ibrutinib in patients with previously untreated chronic lymphocytic leukaemia (CLL) - CLL17
- A Phase 3 Randomized Open-Label Study of Imetelstat Versus Best Available Therapy in Intermediate-2 or High-Risk Myelofibrosis Refractory to JAK-Inhibitors
Data & Insights
Has run more than one trial at 43 of 254 partner sites.
Specializations
Hematologic Malignancies
The investigator specializes in treating chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL), with particular focus on both treatment-naive and relapsed/refractory cases.
- Novel Therapeutic Combinations
- Fixed-Duration Treatment Protocols
- High-Risk Disease Management
Their research extends to innovative treatment approaches for patients with complex disease presentations.
Blood Disorders
The investigator conducts research in transfusion-dependent thalassemia and myelofibrosis, focusing on developing treatments for patients with challenging blood disorders.
- Alpha and Beta Thalassemia Management
- JAK-inhibitor Resistant Cases
- Transfusion Burden Reduction
Their work includes evaluating novel therapeutic agents for improved patient outcomes.
Lymphoid Malignancies
The investigator studies Non-Hodgkin Lymphoma with emphasis on developing new treatment strategies for patients with refractory disease.
- Combination Therapy Approaches
- Antineoplastic Agent Development
- Refractory Disease Treatment
Their research includes evaluating novel agents both as monotherapy and in combination regimens.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.